Jump to content

Langerhans cell

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Chris53516 (talk | contribs) at 08:29, 12 November 2007 (Undid revision 169656037 by 66.30.170.138 (talk) - vandalism). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Langerhans' cells are dendritic cells abundant in epidermis, containing large granules called Birbeck granules and can be found in other organs in the condition Histiocytosis.

Named after German anatomist and physician Paul Langerhans (1847-1888) who described it in skin while a medical student.

Function

On infection of an area of skin, the local Langerhans' cells will take up and process microbial antigens to become fully-functional antigen-presenting cells.

Generally, dendritic cells in tissue are active in the capture, uptake and processing of antigens. Once dendritic cells arrive in secondary lymphoid tissue however, they lose these properties while gaining the capacity to interact with naive T-cells.

Langerhans' cells are derived from the cellular differentiation of monocytes with the marker "Gr-1" (also known as "Ly-6c/G"). The differentiation requires stimulation by colony stimulating factor-1.[1] They are similar in morphology and function to macrophages.

Clinical significance

LCH

In the rare disease Langerhans' cell histiocytosis (LCH), an excess of these cells is produced, which can cause damage to skin, bone and other organs.

HIV

Langerhans' cells capture HIV-1 virions by way of Fc receptor binding to antibody-coated virus. Langerhans' cells act as reservoirs for the HIV-1 virus, serving as a site of replication when T-cells become depleted (Robbins Pathology).

Langerhans' cells have been observed in foreskin, vaginal, and oral mucosa of humans; the lower concentrations in oral mucosa suggest that it is not a likely source of HIV infection relative to foreskin and vaginal mucosa.[2]

On March 4 2007 the online Nature Medicine magazine published the letter "Langerin is a natural barrier to HIV-1 transmission by Langerhans cells",[3] written by Dutch scientists which claims "that Langerin is able to scavenge viruses from the surrounding environment, thereby preventing infection", as lead researcher Teunis Geijtenbeek of Vrije University Medical Center in Amsterdam told to YahooNews-HealthDay reporter.

See also

References

  1. ^ Ginhoux F, Tacke F, Angeli V, Bogunovic M, Loubeau M, Dai X, Stanley E, Randolph G, Merad M (2006). "Langerhans cells arise from monocytes in vivo". Nat Immunol. 7 (3): 265–73. PMID 16444257.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ Hussain, LA, Lehner T (1995). "Comparative Investigation of Langerhans' cells and Potential Receptors for HIV in Oral, Genitourinary and Rectal Epithelia". Immunology. 85: 475–484. PMID 7558138.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong M, de Gruijl T, Piguet V, van Kooyk Y, Geijtenbeek T (2007). "Langerin is a natural barrier to HIV-1 transmission by Langerhans cells". Nat Med. 13 (3): 367–71. PMID 17334373.{{cite journal}}: CS1 maint: multiple names: authors list (link)